Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Porphyromonas, a potential predictive biomarker of Pseudomonas aeruginosa pulmonary infection in cystic fibrosis.

Keravec M, Mounier J, Guilloux CA, Fangous MS, Mondot S, Vallet S, Gouriou S, Le Berre R, Rault G, Férec C, Barbier G, Lepage P, Héry-Arnaud G.

BMJ Open Respir Res. 2019 Mar 12;6(1):e000374. doi: 10.1136/bmjresp-2018-000374. eCollection 2019.

2.

Prevalence and dynamics of Lactobacillus sp. in the lower respiratory tract of patients with cystic fibrosis.

Fangous MS, Lazzouni I, Alexandre Y, Gouriou S, Boisramé S, Vallet S, Le Bihan J, Ramel S, Héry-Arnaud G, Le Berre R.

Res Microbiol. 2018 May - Jun;169(4-5):222-226. doi: 10.1016/j.resmic.2018.03.005. Epub 2018 May 23.

PMID:
29800681
3.

Evaluation of quantitative PCR for early diagnosis of Pseudomonas aeruginosa infection in cystic fibrosis: a prospective cohort study.

Héry-Arnaud G, Nowak E, Caillon J, David V, Dirou A, Revert K, Munck MR, Frachon I, Haloun A, Horeau-Langlard D, Le Bihan J, Danner-Boucher I, Ramel S, Pelletier MP, Rosec S, Gouriou S, Poulhazan E, Payan C, Férec C, Rault G, Le Gal G, Le Berre R.

Clin Microbiol Infect. 2017 Mar;23(3):203-207. doi: 10.1016/j.cmi.2016.11.016. Epub 2016 Nov 27.

4.

Duplication of the V3 domain in hepatitis C virus (1b) NS5A protein: Clonal analysis and physicochemical properties related to hepatocellular carcinoma occurrence.

Petsaris O, Vallet S, Le Guillou-Guillemette H, Veillon P, Gouriou S, Barbier G, Nousbaum JB, Saliou P, NKontchou G, Trinchet JC, Lunel-Fabiani F, Payan C.

J Clin Virol. 2016 Jan;74:19-25. doi: 10.1016/j.jcv.2015.11.011. Epub 2015 Dec 1.

PMID:
26655076
5.

Insights into the respiratory tract microbiota of patients with cystic fibrosis during early Pseudomonas aeruginosa colonization.

Keravec M, Mounier J, Prestat E, Vallet S, Jansson JK, Burgaud G, Rosec S, Gouriou S, Rault G, Coton E, Barbier G, Héry-Arnaud G.

Springerplus. 2015 Aug 9;4:405. doi: 10.1186/s40064-015-1207-0. eCollection 2015.

6.

Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin.

Larrat S, Vallet S, David-Tchouda S, Caporossi A, Margier J, Ramière C, Scholtes C, Haïm-Boukobza S, Roque-Afonso AM, Besse B, André-Garnier E, Mohamed S, Halfon P, Pivert A, LeGuillou-Guillemette H, Abravanel F, Guivarch M, Mackiewicz V, Lada O, Mourez T, Plantier JC, Baazia Y, Alain S, Hantz S, Thibault V, Gaudy-Graffin C, Bouvet D, Mirand A, Henquell C, Gozlan J, Lagathu G, Pronier C, Velay A, Schvoerer E, Trimoulet P, Fleury H, Bouvier-Alias M, Brochot E, Duverlie G, Maylin S, Gouriou S, Pawlotsky JM, Morand P.

J Clin Microbiol. 2015 Jul;53(7):2195-202. doi: 10.1128/JCM.03633-14. Epub 2015 Apr 29.

7.

Pseudomonas aeruginosa and Periodontal Pathogens in the Oral Cavity and Lungs of Cystic Fibrosis Patients: a Case-Control Study.

Rivas Caldas R, Le Gall F, Revert K, Rault G, Virmaux M, Gouriou S, Héry-Arnaud G, Barbier G, Boisramé S.

J Clin Microbiol. 2015 Jun;53(6):1898-907. doi: 10.1128/JCM.00368-15. Epub 2015 Apr 8.

8.

Impact of the CFTR-potentiator ivacaftor on airway microbiota in cystic fibrosis patients carrying a G551D mutation.

Bernarde C, Keravec M, Mounier J, Gouriou S, Rault G, Férec C, Barbier G, Héry-Arnaud G.

PLoS One. 2015 Apr 8;10(4):e0124124. doi: 10.1371/journal.pone.0124124. eCollection 2015.

9.

Classification algorithm for subspecies identification within the Mycobacterium abscessus species, based on matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Fangous MS, Mougari F, Gouriou S, Calvez E, Raskine L, Cambau E, Payan C, Héry-Arnaud G.

J Clin Microbiol. 2014 Sep;52(9):3362-9. doi: 10.1128/JCM.00788-14. Epub 2014 Jul 9.

10.

Proposal of a quantitative PCR-based protocol for an optimal Pseudomonas aeruginosa detection in patients with cystic fibrosis.

Le Gall F, Le Berre R, Rosec S, Hardy J, Gouriou S, Boisramé-Gastrin S, Vallet S, Rault G, Payan C, Héry-Arnaud G.

BMC Microbiol. 2013 Jun 21;13:143. doi: 10.1186/1471-2180-13-143.

11.

Probiotics: a new way to fight bacterial pulmonary infections?

Alexandre Y, Le Blay G, Boisramé-Gastrin S, Le Gall F, Héry-Arnaud G, Gouriou S, Vallet S, Le Berre R.

Med Mal Infect. 2014 Jan;44(1):9-17. doi: 10.1016/j.medmal.2013.05.001. Epub 2013 Jun 29. Review.

PMID:
23820129
12.

Multicenter quality control of hepatitis C virus protease inhibitor resistance genotyping.

Vallet S, Larrat S, Laperche S, Le Guillou-Guillemette H, Legrand-Abravanel F, Bouchardeau F, Pivert A, Henquell C, Mirand A, André-Garnier E, Giordanengo V, Lagathu G, Thibault V, Scholtes C, Schvoerer E, Gaudy-Graffin C, Maylin S, Trimoulet P, Brochot E, Hantz S, Gozlan J, Roque-Afonso AM, Soussan P, Plantier JC, Charpentier C, Chevaliez S, Colson P, Mackiewicz V, Aguilera L, Rosec S, Gouriou S, Magnat N, Lunel-Fabiani F, Izopet J, Morand P, Payan C, Pawlotsky JM.

J Clin Microbiol. 2013 May;51(5):1428-33. doi: 10.1128/JCM.03032-12. Epub 2013 Feb 20.

13.

Severity of Escherichia coli bacteraemia is independent of the intrinsic virulence of the strains assessed in a mouse model.

Landraud L, Jauréguy F, Frapy E, Guigon G, Gouriou S, Carbonnelle E, Clermont O, Denamur E, Picard B, Lemichez E, Brisse S, Nassif X.

Clin Microbiol Infect. 2013 Jan;19(1):85-90. doi: 10.1111/j.1469-0691.2011.03750.x. Epub 2012 Jan 23.

14.

NS3 protease polymorphism and natural resistance to protease inhibitors in French patients infected with HCV genotypes 1-5.

Vallet S, Viron F, Henquell C, Le Guillou-Guillemette H, Lagathu G, Abravanel F, Trimoulet P, Soussan P, Schvoerer E, Rosenberg A, Gouriou S, Colson P, Izopet J, Payan C; ANRS AC11 HCV Group.

Antivir Ther. 2011;16(7):1093-102. doi: 10.3851/IMP1900.

PMID:
22024525
15.

Salmonella carriage in adopted children from Mali: 2001-08.

Boisramé-Gastrin S, Tandé D, Münck MR, Gouriou S, Nordmann P, Naas T.

J Antimicrob Chemother. 2011 Oct;66(10):2271-6. doi: 10.1093/jac/dkr307. Epub 2011 Jul 29.

PMID:
21803770
16.

Epidemiological status of extended spectrum betalactamase producing Klebsiella pneumoniae in sub-Saharian Africa (Mali) in international adoption.

Boisrame-Gastrin S, Chaffanel F, Münck MR, Gouriou S, Tandé D.

Bull Group Int Rech Sci Stomatol Odontol. 2011 Nov 22;50(2):7-8. No abstract available.

PMID:
22750696
17.

Intrafamilial transmission of extended-spectrum-beta-lactamase-producing Escherichia coli and Salmonella enterica Babelsberg among the families of internationally adopted children.

Tandé D, Boisramé-Gastrin S, Münck MR, Héry-Arnaud G, Gouriou S, Jallot N, Nordmann P, Naas T.

J Antimicrob Chemother. 2010 May;65(5):859-65. doi: 10.1093/jac/dkq068. Epub 2010 Mar 16.

PMID:
20233775
18.

Fatal case of enterovirus 71 infection, France, 2007.

Vallet S, Legrand Quillien MC, Dailland T, Podeur G, Gouriou S, Schuffenecker I, Payan C, Marcorelles P.

Emerg Infect Dis. 2009 Nov;15(11):1837-40. doi: 10.3201/eid1511.090493. Erratum in: Emerg Infect Dis. 2009 Dec;15(12):2079.

19.

Extended-spectrum beta-lactamase-producing Enterobacteriaceae in a Malian orphanage.

Tandé D, Jallot N, Bougoudogo F, Montagnon T, Gouriou S, Sizun J.

Emerg Infect Dis. 2009 Mar;15(3):472-4. doi: 10.3201/eid1503.071637.

20.

Extraintestinal virulence is a coincidental by-product of commensalism in B2 phylogenetic group Escherichia coli strains.

Le Gall T, Clermont O, Gouriou S, Picard B, Nassif X, Denamur E, Tenaillon O.

Mol Biol Evol. 2007 Nov;24(11):2373-84. Epub 2007 Aug 19.

PMID:
17709333
21.

Is hepatitis C virus NS3 protease quasispecies heterogeneity predictive of progression from cirrhosis to hepatocellular carcinoma?

Vallet S, Gouriou S, Nkontchou G, Hotta H, Vilerio M, Legrand-Quillien MC, Beaugrand M, Trinchet JC, Nousbaum JB, Dény P, Gaudy C, Goudeau A, Picard B, Payan C.

J Viral Hepat. 2007 Feb;14(2):96-106.

PMID:
17244249
22.

Caenorhabditis elegans as a simple model to study phenotypic and genetic virulence determinants of extraintestinal pathogenic Escherichia coli.

Diard M, Baeriswyl S, Clermont O, Gouriou S, Picard B, Taddei F, Denamur E, Matic I.

Microbes Infect. 2007 Feb;9(2):214-23. Epub 2006 Dec 8.

23.

Identification of forces shaping the commensal Escherichia coli genetic structure by comparing animal and human isolates.

Escobar-Páramo P, Le Menac'h A, Le Gall T, Amorin C, Gouriou S, Picard B, Skurnik D, Denamur E.

Environ Microbiol. 2006 Nov;8(11):1975-84.

24.

Genetic heterogeneity of the NS3 protease gene in hepatitis C virus genotype 1 from untreated infected patients.

Vallet S, Gouriou S, Nousbaum JB, Legrand-Quillien MC, Goudeau A, Picard B.

J Med Virol. 2005 Apr;75(4):528-37.

PMID:
15714495
25.

Genetic background of Escherichia coli and extended-spectrum beta-lactamase type.

Branger C, Zamfir O, Geoffroy S, Laurans G, Arlet G, Thien HV, Gouriou S, Picard B, Denamur E.

Emerg Infect Dis. 2005 Jan;11(1):54-61.

26.

A particular hepatitis C virus protease NS3 gene pattern in a patient not responding to interferon-ribavirin therapy.

Vallet S, Nousbaum JB, Gouriou S, Legrand-Quillien MC, Goudeau A, Picard B.

Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):79-80. No abstract available.

PMID:
15616841
27.

Large-scale population structure of human commensal Escherichia coli isolates.

Escobar-Páramo P, Grenet K, Le Menac'h A, Rode L, Salgado E, Amorin C, Gouriou S, Picard B, Rahimy MC, Andremont A, Denamur E, Ruimy R.

Appl Environ Microbiol. 2004 Sep;70(9):5698-700.

28.

Mycobacterium szulgai isolated from a patient, a tropical fish and aquarium water.

Abalain-Colloc ML, Guillerm D, Saläun M, Gouriou S, Vincent V, Picard B.

Eur J Clin Microbiol Infect Dis. 2003 Dec;22(12):768-9. Epub 2003 Nov 6. No abstract available.

PMID:
14605942
29.

The FimH A27V mutation is pathoadaptive for urovirulence in Escherichia coli B2 phylogenetic group isolates.

Hommais F, Gouriou S, Amorin C, Bui H, Rahimy MC, Picard B, Denamur E.

Infect Immun. 2003 Jun;71(6):3619-22.

30.

Yersinia high-pathogenicity island contributes to virulence in Escherichia coli causing extraintestinal infections.

Schubert S, Picard B, Gouriou S, Heesemann J, Denamur E.

Infect Immun. 2002 Sep;70(9):5335-7.

31.

Mutator natural Escherichia coli isolates have an unusual virulence phenotype.

Picard B, Duriez P, Gouriou S, Matic I, Denamur E, Taddei F.

Infect Immun. 2001 Jan;69(1):9-14.

32.

The link between phylogeny and virulence in Escherichia coli extraintestinal infection.

Picard B, Garcia JS, Gouriou S, Duriez P, Brahimi N, Bingen E, Elion J, Denamur E.

Infect Immun. 1999 Feb;67(2):546-53.

Supplemental Content

Loading ...
Support Center